Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RARB | P10826 | 7/20 | 0.59 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.59 |
| ▸ | TSHR | P16473 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.58 |
| ▸ | MEN1 | O00255 | 2/20 | 0.58 |
| ▸ | MAPT | P10636 | 2/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.58 |
| ▸ | RARA | P10276 | 1/20 | 0.58 |
| ▸ | MTOR | P42345 | 1/20 | 0.58 |
| ▸ | RAB9A | P51151 | 2/20 | 0.56 |
| ▸ | NPC1 | O15118 | 1/20 | 0.56 |
| ▸ | ATM | Q13315 | 1/20 | 0.56 |
| ▸ | ESR1 | P03372 | 2/20 | 0.55 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.55 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.55 |
| ▸ | TACR2 | P21452 | 2/20 | 0.55 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.55 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.55 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30577318 | 0.98 | HSD17B10 (0.62) | RARBHSD17B10TSHRALDH1A1MEN1 | |
| SCHEMBL28385904 | 0.98 | HSD17B10 (0.62) | RARBHSD17B10TSHRALDH1A1MEN1 | |
| SCHEMBL2492800 | 0.93 | RARB (0.58) | RARBHSD17B10TSHRALDH1A1MEN1 | |
| SCHEMBL392911 | 0.93 | ESR1 (0.61) | HSD17B10ALDH1A1RAB9ANPC1ATM | |
| SCHEMBL9678943 | 0.91 | ESR1 (0.65) | HSD17B10TSHRALDH1A1ESR1ADRA2A | |
| Octane SCHEMBL9724037 | 0.91 | ESR1 (0.65) | HSD17B10TSHRALDH1A1ESR1ADRA2A | |
| SCHEMBL396014 | 0.91 | ESR1 (0.65) | HSD17B10TSHRALDH1A1ESR1ADRA2A | |
| SCHEMBL21963890 | 0.91 | ESR1 (0.65) | HSD17B10TSHRALDH1A1ESR1ADRA2A | |
| SCHEMBL168031 | 0.91 | ESR1 (0.65) | HSD17B10TSHRALDH1A1ESR1ADRA2A | |
| SCHEMBL80498 | 0.91 | ESR1 (0.65) | HSD17B10TSHRALDH1A1ESR1ADRA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119438433-A | Based on UiO-66-F4Method for analyzing liquid crystal monomer in indoor dust by solid phase extraction-high performance liquid chromatography | 北京工业大学 | 2025-02-14 | — | — | CN | claimed |
| WO-2023005682-A1 | METHOD FOR ANALYZING TARGETED EXPOSURE GROUP OF ENVIRONMENTAL POLLUTANTS IN PLASMA, AND USE THEREOF | 暨南大学 | 2023-02-02 | — | — | WO | claimed |
| US-7335405-B2 | Nematic liquid crystal mixtures for use in bistable display devices | NEMOPTIC (FR) | 2008-02-26 | — | — | US | claimed |
| US-20060249708-A1 | Nematic liquid crystal mixtures for use in bistable display devices | CDC PROPRIETE INTELLECTUELLE (FR) | 2006-11-09 | — | — | US | claimed |
| US-4198130-A | Liquid crystal mixtures | HOFFMANN-LA ROCHE INC. (US) | 1980-04-15 | — | — | US | claimed |
| US-4180475-A | POSITIVE ANISOTROPY OF DIELECTRIC CONSTANTS | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1979-12-25 | — | — | US | claimed |
| CN-119555817-A | Pretreatment method for efficiently extracting trace liquid crystal monomer from water based on membrane filtration technology | 南京理工大学 | 2025-03-04 | — | — | CN | disclosed |
| WO-2023167325-A1 | IMMOBILIZED PALLADIUM CATALYST AND METHOD FOR PRODUCING SAME, AND APPLICATION OF THIS CATALYST TO COUPLING REACTION | 国立研究開発法人理化学研究所 | 2023-09-07 | — | — | WO | disclosed |
| CN-113671068-B | Method for analyzing environmental pollutant targeted exposure group in blood plasma and application thereof | 暨南大学 | 2023-01-24 | — | — | CN | disclosed |
| US-9624434-B2 | Nematic liquid crystal composition and liquid crystal display device using the same | DIC CORPORATION (JP) | 2017-04-18 | — | — | US | disclosed |
| WO-2013038149-A1 | OPTICAL DEVICE | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2013-03-21 | — | — | WO | disclosed |
| US-20120022024-A1 | ANTI-BACTERIAL COMPOSITIONS AND METHODS INCLUDING TARGETING VIRULENCE FACTORS OF STAPHYLOCOCCUS AUREUS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2012-01-26 | — | — | US | disclosed |
| US-7335405-B2 | Nematic liquid crystal mixtures for use in bistable display devices | NEMOPTIC (FR) | 2008-02-26 | — | — | US | disclosed |
| US-20060249708-A1 | Nematic liquid crystal mixtures for use in bistable display devices | CDC PROPRIETE INTELLECTUELLE (FR) | 2006-11-09 | — | — | US | disclosed |
| EP-0167912-B1 | LIQUID CRYSTAL MIXTURES CONTAINING COMPOUNDS WITH A 4-ALKENYL OR 2Z-ALKENYL LATERAL CHAIN | F. HOFFMANN-LA ROCHE AG (CH) | 1990-01-03 | — | — | EP | disclosed |
| EP-0167912-A2 | Liquid crystal mixtures containing compounds with a 4-alkenyl or 2Z-alkenyl lateral chain | F. HOFFMANN-LA ROCHE AG (CH) | 1986-01-15 | — | — | EP | disclosed |
| US-4198130-A | Liquid crystal mixtures | HOFFMANN-LA ROCHE INC. (US) | 1980-04-15 | — | — | US | disclosed |
| US-4180475-A | POSITIVE ANISOTROPY OF DIELECTRIC CONSTANTS | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1979-12-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120022024-A1 | ANTI-BACTERIAL COMPOSITIONS AND METHODS INCLUDING TARGETING VIRULENCE FACTORS OF STAPHYLOCOCCUS AUREUS | CUTA, MMP8, CLPP | RARB 3294/4885HSD17B10 3345/4885TSHR 4335/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.